Related Experiment Video

Updated: May 7, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Role of microRNAs in hepatocellular carcinoma: a clinical perspective

Elisa Callegari1, Bahaeldin K Elamin, Silvia Sabbioni

  • 1Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università di Ferrara, Ferrara, Italy.

Oncotargets and Therapy
|September 17, 2013
PubMed

Insights

MicroRNAs (miRNAs) show promise in diagnosing and treating hepatocellular carcinoma (HCC). Research explores their potential as biomarkers and therapeutic agents against this deadly cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited effective treatments.
  • MicroRNAs (miRNAs) play a crucial role in hepatocarcinogenesis, acting as oncogenes or tumor suppressors.
  • miRNAs are implicated in regulating key proteins within cancer-associated pathways.

Purpose of the Study:

  • To investigate the clinical applications of microRNAs in hepatocellular carcinoma.
  • To explore miRNAs as diagnostic and prognostic tools for HCC.
  • To evaluate the therapeutic potential of miRNA-based strategies in HCC.

Main Methods:

  • Review of preclinical studies on miRNA involvement in HCC.
  • Analysis of miRNA stability and tumor-specific expression for diagnostic potential.
  • Investigation of anti-miRNA oligonucleotides, miRNA mimics, and oncolytic viruses for therapy.

Main Results:

  • miRNAs demonstrate potential as diagnostic biomarkers for HCC classification and prognosis due to their specific expression and stability.
  • Preclinical studies show that anti-miRNA oligonucleotides and miRNA mimics possess antitumor activity.
  • Targeting tumor cells with oncolytic viruses is enhanced by exploiting tumor-specific miRNA expression.

Conclusions:

  • MicroRNAs represent a significant area of investigation for HCC clinical applications.
  • miRNA-based approaches offer potential for novel diagnostic and therapeutic strategies in HCC.
  • Further research is needed to fully assess the clinical value of miRNAs in HCC and cancer treatment.
Keywords:
hepatocellular carcinomamicroRNAmicromarkersoncolytic viruses

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...